These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24545426)

  • 21. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Energy deposition by a 106Ru/106Rh eye applicator simulated using LEPTS, a low-energy particle track simulation.
    Fuss MC; Muñoz A; Oller JC; Blanco F; Williart A; Limão-Vieira P; Borge MJ; Tengblad O; Huerga C; Téllez M; García G
    Appl Radiat Isot; 2011 Sep; 69(9):1198-204. PubMed ID: 21543231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Pt-Ru@PThB catalyst by gamma-irradiation and NaBH(4) as reducing agent.
    Ryu JH; Jung SH; Sim KS; Choi SH
    Appl Radiat Isot; 2009; 67(7-8):1449-53. PubMed ID: 19307126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
    Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the coefficients of accumulation and distribution of ruthenium-106 in the organs and tissues of marine molluscs].
    Zesenko AIa; Polikarpov GG
    Radiobiologiia; 1965; 5(2):320-2. PubMed ID: 5871981
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
    Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Method for source localization proposed and applied to the October 2017 case of atmospheric dispersion of Ru-106.
    Sørensen JH
    J Environ Radioact; 2018 Sep; 189():221-226. PubMed ID: 29702454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
    Pe'er J; Averbukh E; Frenkel S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
    [No Abstract]   [Full Text] [Related]  

  • 29. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma.
    Takiar V; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
    Pract Radiat Oncol; 2014; 4(4):e189-94. PubMed ID: 25012839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Brachytherapy using Ru-106 applicators in ophthalmology].
    Binder W; Menapace R; Seitz W
    Strahlenther Onkol; 1990 Oct; 166(10):639-42. PubMed ID: 2237745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques.
    Kaulich TW; Zurheide J; Haug T; Budach W; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2004 Jun; 180(6):358-64. PubMed ID: 15175870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of excitation functions of helion-induced reactions on enriched Ru targets for production of medically important 103Pd and 101mRh and some other radionuclides.
    Skakun Y; Qaim SM
    Appl Radiat Isot; 2008 May; 66(5):653-67. PubMed ID: 18206377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of (99m)Tc from a commercial (99)Mo/(99m)Tc generator as yield tracer for the determination of (99)Tc at low levels.
    Hou X; Jensen M; Nielsen SP
    Appl Radiat Isot; 2007 May; 65(5):610-8. PubMed ID: 17350274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of algisorb on the level of the accumulation of zirconium, ruthenium, iodine and cesium radioactive isotopes in the body of rats].
    Ivannikov AT; Altukhova GA; Parfenova IM; Popov BA
    Radiats Biol Radioecol; 1996; 36(3):427-33. PubMed ID: 8704921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients.
    Cho Y; Chang JS; Yoon JS; Lee SC; Kim YB; Kim JH; Keum KC
    Cancer Res Treat; 2018 Jan; 50(1):138-147. PubMed ID: 28343376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Ruthenium-106 Brachytherapy for Iris Melanoma: The Scottish Experience.
    Agraval U; Sobti M; Russell HC; Lockington D; Ritchie D; Cauchi P; Kemp EG; Chadha V
    Br J Ophthalmol; 2018 Jan; 102(1):74-78. PubMed ID: 28600302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative metabolism of selected radionuclides in animals.
    Stara JF; Nelson NS; Della Rosa RJ; Bustad LK
    Environ Health Ser Radiol Health; 1968 Sep; 33():45-50. PubMed ID: 4978769
    [No Abstract]   [Full Text] [Related]  

  • 38. Dosimetry of ruthenium-106 eye applicators.
    Davelaar J; Schaling DF; Hennen LA; Broerse JJ
    Med Phys; 1992; 19(3):691-4. PubMed ID: 1508109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Accumulation of radioactive isotopes of strontium, ruthenium, cesium and cerium by some bacteria].
    ZHAROVA TV
    Mikrobiologiia; 1961; 30():871-6. PubMed ID: 14010200
    [No Abstract]   [Full Text] [Related]  

  • 40. Need for confirmation of positioning of ruthenium plaques by postoperative B-scan ultrasonography.
    Anteby II; Pe'er J
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1024-9. PubMed ID: 8976522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.